about
Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancerLow-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cellsAndrogen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cellsGlucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancerFormation of human prostate epithelium using tissue recombination of rodent urogenital sinus mesenchyme and human stem cellsDNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer.HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directionsThe pluripotency factor Nanog is directly upregulated by the androgen receptor in prostate cancer cellsConversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression.Sox2 Expression Marks Castration-Resistant Progenitor Cells in the Adult Murine ProstateSuppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic DiseasePEG10 Promoter-Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate CancerMEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans
P50
Q24633279-EA301371-7CC6-43CE-A97E-E69566242E6CQ34013781-CE02001C-2F56-4A33-A19D-DE41A4179276Q34773058-46DA0AD9-A372-46C1-A4A4-B175D17031B4Q35108085-144774F4-97E3-482A-B73D-38C0AD9FEABBQ35631971-BE001F9D-7DA7-45A9-9BF0-B38F4F8A729CQ37058289-4CC75C83-66F8-4E20-8391-4D6D973CC3A3Q37400428-9DF69B5C-FFE2-4216-8C1A-E6C505AD6FE2Q38629410-D405CD1E-88B1-4D4A-8AFB-CEF604FEA2CCQ38961091-C429664B-6419-4545-8D22-6D67FAF684C3Q38982717-622BD944-711D-43B4-BB72-1D9DEC517FEDQ40314276-1C99DEBC-E5EE-4A71-AA49-62CE105DFE75Q42105215-372609BE-97B3-424D-B05A-2C3275CBE72CQ64240246-6125C948-C1E5-4878-B6EF-9DD69D2CA5DFQ81562239-F1D35BFE-52B6-4572-8815-4320E227F721Q88537040-E8504E39-868C-4400-9CC8-0563F7E38E20Q90147923-1FD08FD6-9408-4A64-95CC-F0CD74FCE496Q96585131-79774DC9-0AC2-42C0-B16A-539D6E2CB4B7
P50
description
researcher ORCID ID = 0000-0003-4421-5698
@en
wetenschapper
@nl
name
Donald J Vander Griend
@ast
Donald J Vander Griend
@en
Donald J Vander Griend
@es
Donald J Vander Griend
@nl
type
label
Donald J Vander Griend
@ast
Donald J Vander Griend
@en
Donald J Vander Griend
@es
Donald J Vander Griend
@nl
prefLabel
Donald J Vander Griend
@ast
Donald J Vander Griend
@en
Donald J Vander Griend
@es
Donald J Vander Griend
@nl
P106
P1153
6603031541
P31
P496
0000-0003-4421-5698